These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 20013146)
1. Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. Guevara P; Escobar-Arriaga E; Saavedra-Perez D; Martinez-Rumayor A; Flores-Estrada D; Rembao D; Calderon A; Sotelo J; Arrieta O J Neurooncol; 2010 Jul; 98(3):379-84. PubMed ID: 20013146 [TBL] [Abstract][Full Text] [Related]
2. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437 [TBL] [Abstract][Full Text] [Related]
3. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937 [TBL] [Abstract][Full Text] [Related]
4. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse. Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825 [TBL] [Abstract][Full Text] [Related]
6. Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201 [TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors in cerebral meningioma and their clinical value]. Kvasha MS; Zakhartsev LM Klin Khir; 2002 Sep; (8):50-2. PubMed ID: 12378940 [TBL] [Abstract][Full Text] [Related]
8. Is progesteron receptor status really a prognostic factor for intracranial meningiomas? Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873 [TBL] [Abstract][Full Text] [Related]
9. Specific genes expressed in association with progesterone receptors in meningioma. Claus EB; Park PJ; Carroll R; Chan J; Black PM Cancer Res; 2008 Jan; 68(1):314-22. PubMed ID: 18172325 [TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays. Halper J; Colvard DS; Scheithauer BW; Jiang NS; Press MF; Graham ML; Riehl E; Laws ER; Spelsberg TC Neurosurgery; 1989 Oct; 25(4):546-52; discussion 552-3. PubMed ID: 2477767 [TBL] [Abstract][Full Text] [Related]
11. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. Pravdenkova S; Al-Mefty O; Sawyer J; Husain M J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818 [TBL] [Abstract][Full Text] [Related]
12. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Nassehi D Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727 [TBL] [Abstract][Full Text] [Related]
13. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Blankenstein MA; Verheijen FM; Jacobs JM; Donker TH; van Duijnhoven MW; Thijssen JH Steroids; 2000; 65(10-11):795-800. PubMed ID: 11108890 [TBL] [Abstract][Full Text] [Related]
14. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138 [TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis. Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. LeĆ£es CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265 [TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital. Ikeri NZ; Anunobi CC; Bankole OB Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340 [TBL] [Abstract][Full Text] [Related]
18. Fertility treatment is associated with multiple meningiomas and younger age at diagnosis. Shahin MN; Magill ST; Dalle Ore CL; Viner JA; Peters PN; Solomon DA; McDermott MW J Neurooncol; 2019 May; 143(1):137-144. PubMed ID: 30868355 [TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas. Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792 [TBL] [Abstract][Full Text] [Related]
20. Progesterone and estrogen receptors in meningiomas: prognostic considerations. Hsu DW; Efird JT; Hedley-Whyte ET J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]